Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Recursion Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 332 institutions reported holding Recursion Pharmaceuticals, Inc., 67.6% of its shares. Largest: Vanguard, BlackRock and ARK. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Recursion Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 58.1M | 10.9% | +8.86M | Aug 13, 2026 |
| BlackRock | 50.3M | 9.4% | +7.11M | Aug 7, 2026 |
| ARK | 41.3M | 7.7% | +1.12M | Aug 14, 2026 |
| State Street | 34.7M | 6.5% | +6.22M | Aug 7, 2026 |
| Baillie Gifford & Co | 23.5M | 4.4% | −188K | Aug 6, 2026 |
| Geode Capital | 13.8M | 2.6% | +1.54M | Aug 12, 2026 |
| Softbank Group Corp. | 13.6M | 2.5% | no change | Aug 14, 2026 |
| UBS | 9.71M | 1.8% | +583K | Aug 13, 2026 |
| MIC Capital Management UK LLP | 9.64M | 1.8% | +1 | Aug 10, 2026 |
| Norges Bank | 6.83M | 1.3% | first report | Aug 12, 2026 |